ESPERION THERAPEUTICS INC (ESPR) Stock Income Statement
USA - NASDAQ:ESPR - US29664W1053 - Common Stock
2.83 USD
+0.01 (+0.35%)
2.8325 USD
+0 (+0.09%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 303.80M | 332.31M | 116.33M | 75.50M | 78.40M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | 127.00M | 68.60M | 43.27M | 27.00M | 14.20M | |||
| Gross Profit | 176.80M | 263.71M | 73.07M | 48.50M | 64.20M | |||
| Operating Expenses | 206.18M | 209.31M | 228.63M | 228.00M | 277.70M | |||
| Research and Development | 44.90M | 46.24M | 86.11M | 118.90M | 106.00M | |||
| Selling, General, and Administrative Expenses | 161.28M | 163.07M | 142.52M | 109.10M | 171.70M | |||
| Operating Income | -29.38M | 54.40M | -155.56M | -179.50M | -213.40M | |||
| Interest Income/Expense | -74.79M | -51.65M | -54.58M | -54.40M | -46.30M | |||
| Other Income/Expense | 22.00K | 422.00K | 891.00K | 300.00K | 3.90M | |||
| Non Recurring Items | null | -54.92M | null | null | -13.30M | |||
| Income Before Taxes | -105.83M | -51.74M | -209.25M | -233.70M | -269.10M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -105.83M | -51.74M | -209.25M | -233.70M | -269.10M | |||
| EBITDA | -29.27M | 54.47M | -155.40M | -179.00M | -212.79M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.5357999999999999 | -0.2764 | -2.0294 | -3.52 | -9.31 | |||
| Non GAAP EPS | -0.5 | -0.25000000000000006 | -2.12 | -3.5500000000000003 | -9.56 | |||
| Statistics | ||||||||
| Gross Profit Margin | 58.20% | 79.36% | 62.81% | 64.24% | 81.89% | |||
| Profit Margin | -34.84% | -15.57% | -179.87% | -309.54% | -343.24% | |||
| Operating Profit Margin | -9.67% | 16.37% | -133.72% | -237.75% | -272.19% | |||
All data in USD